Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy
Full IRB Study Title:
A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy
IRB Study ID: 2022-177
For complete information, please visit the study on Clinicaltrials.gov
Study Sponsor:
Capricor, Inc.
We are currently recruiting
If you are interested in this study or have questions about your child's eligibility, please contact:
Hilary Tonni, RN
330-543-4734
htonni@akronchildrens.org
Lead Investigator
Kathryn Mosher, MD
Pediatric Physiatrist; Director, Neuromuscular Clinic
NeuroDevelopmental Science CenterPhysical Medicine and RehabilitationPediatric Neuromuscular ClinicPediatric Brain Tumor ProgramPediatric Spasticity ClinicInpatient Rehabilitation ProgramDay Rehabilitation Program